Status:
UNKNOWN
Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Conditions:
Anticandidal Property of Saccharomyces Boulardii on Very Low Birth Weight Infants
Eligibility:
All Genders
1-90 years
Phase:
PHASE4
Brief Summary
Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Saccharomyces boulardii was shown to reduce candida colonization. The ob...
Eligibility Criteria
Inclusion
- Very low birth weight infants \< 1500 gr
Exclusion
- Genetic anomalies
- Not willing to participate
- Allergy to S. boulardii components
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01411748
Start Date
July 1 2011
End Date
December 1 2011
Last Update
August 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology
Ankara, Turkey (Türkiye), 06230